Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Retained Earnings (2016 - 2021)

Phio Pharmaceuticals' Retained Earnings history spans 10 years, with the latest figure at -$113.4 million for Q3 2021.

  • For Q3 2021, Retained Earnings fell 12.16% year-over-year to -$113.4 million; the TTM value through Sep 2021 reached -$113.4 million, down 12.16%, while the annual FY2020 figure was -$103.6 million, 9.27% down from the prior year.
  • Retained Earnings reached -$113.4 million in Q3 2021 per PHIO's latest filing, down from -$109.7 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$71.6 million in Q1 2017 to a low of -$113.4 million in Q3 2021.
  • Average Retained Earnings over 5 years is -$91.1 million, with a median of -$90.1 million recorded in 2019.
  • Peak YoY movement for Retained Earnings: dropped 20.6% in 2017, then decreased 8.92% in 2019.
  • A 5-year view of Retained Earnings shows it stood at -$78.6 million in 2017, then decreased by 9.37% to -$85.9 million in 2018, then fell by 10.37% to -$94.8 million in 2019, then decreased by 9.27% to -$103.6 million in 2020, then dropped by 9.49% to -$113.4 million in 2021.
  • Per Business Quant, the three most recent readings for PHIO's Retained Earnings are -$113.4 million (Q3 2021), -$109.7 million (Q2 2021), and -$107.0 million (Q1 2021).